See more : Tianjin Pengling Group Co.,Ltd (300375.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Syncom Healthcare Limited (SYNCOM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Syncom Healthcare Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Lam Research Corporation (LRCX) Income Statement Analysis – Financial Results
- Water Intelligence plc (WTLLF) Income Statement Analysis – Financial Results
- Changsha Tongcheng Holdings Co.Ltd (000419.SZ) Income Statement Analysis – Financial Results
- United Rail, Inc. (URAL) Income Statement Analysis – Financial Results
- KEI Industries Limited (KEI.NS) Income Statement Analysis – Financial Results
Syncom Healthcare Limited (SYNCOM.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.syncomhealthcare.in
About Syncom Healthcare Limited
Syncom Healthcare Limited produces, markets, and distributes pharmaceutical formulations in India and internationally. It also exports its products. Syncom Healthcare Limited was incorporated in 2002 and is based in Mumbai, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 18.32M | 199.67M | 641.24M | 415.30M | 555.47M | 1.24B | 1.91B | 1.92B | 2.04B | 1.35B | 755.91M | 668.51M | 605.65M |
| Cost of Revenue | 0.00 | 0.00 | 62.45M | 207.41M | 569.15M | 241.97M | 416.13M | 1.02B | 1.67B | 1.72B | 1.79B | 1.10B | 700.92M | 478.50M | 415.94M |
| Gross Profit | 0.00 | 0.00 | -44.13M | -7.74M | 72.09M | 173.34M | 139.34M | 219.33M | 238.14M | 191.45M | 251.47M | 252.36M | 54.99M | 190.01M | 189.70M |
| Gross Profit Ratio | 0.00% | 0.00% | -240.88% | -3.87% | 11.24% | 41.74% | 25.09% | 17.70% | 12.46% | 9.99% | 12.31% | 18.70% | 7.27% | 28.42% | 31.32% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 5.15M | 8.92M | 8.75M | 5.10M | 10.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 99.73M | 90.47M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 12.92M | 74.20M | 49.99M | 35.66M | 45.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 8.83M | 108.75M | 119.37M | 58.74M | 40.76M | 55.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 99.73M | 90.47M |
| Other Expenses | 0.00 | 0.00 | 45.55M | -403.00K | -571.00K | 260.79M | 1.01B | 194.47M | 268.99M | 255.49M | 197.21M | 185.37M | -13.90M | 18.16M | 20.27M |
| Operating Expenses | 0.00 | 0.00 | 8.83M | 109.16M | 119.94M | 319.53M | 1.05B | 250.28M | 268.99M | 255.49M | 197.21M | 185.37M | -13.90M | 117.89M | 110.74M |
| Cost & Expenses | 0.00 | 0.00 | 71.29M | 316.57M | 689.09M | 561.50M | 1.47B | 1.27B | 1.94B | 1.98B | 1.99B | 1.28B | 687.02M | 596.39M | 526.69M |
| Interest Income | 0.00 | 0.00 | 0.00 | 1.02M | 798.00K | 723.00K | 797.48K | 25.36M | 22.36M | 28.05M | 22.35M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 219.00K | 2.89M | 4.15M | 168.00K | 28.50M | 31.18M | 41.72M | 0.00 | 0.00 | 0.00 | 19.64M | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 19.92M | 22.91M | 29.32M | 37.39M | 46.05M | 41.47M | 58.49M | 42.68M | 22.89M | 23.23M | 18.35M | 18.89M | 22.14M |
| EBITDA | 0.00 | 0.00 | -33.04M | -93.98M | -18.53M | -157.17M | -897.57M | 9.22M | 47.00M | -33.02M | 62.76M | 65.25M | 45.82M | 64.05M | 65.56M |
| EBITDA Ratio | 0.00% | 0.00% | -180.36% | -47.07% | -2.89% | -179.34% | -274.48% | 2.45% | 2.46% | -1.72% | 3.07% | 4.84% | 6.06% | 9.58% | 10.83% |
| Operating Income | 0.00 | 0.00 | -52.96M | -116.89M | -47.85M | -146.19M | -911.10M | -30.95M | -30.85M | -64.03M | 54.27M | 66.99M | 68.89M | 72.12M | 78.96M |
| Operating Income Ratio | 0.00% | 0.00% | -289.09% | -58.54% | -7.46% | -35.20% | -164.02% | -2.50% | -1.61% | -3.34% | 2.66% | 4.96% | 9.11% | 10.79% | 13.04% |
| Total Other Income/Expenses | 0.00 | 0.00 | 3.87M | -297.00K | -66.33M | -636.17M | -688.08M | -11.36M | -22.37M | 31.89M | -14.40M | -24.97M | -61.06M | -26.97M | -35.53M |
| Income Before Tax | 0.00 | 0.00 | -49.10M | -117.19M | -114.18M | -782.36M | -1.60B | -42.31M | -53.22M | -32.15M | 39.87M | 42.02M | 7.83M | 45.15M | 43.43M |
| Income Before Tax Ratio | 0.00% | 0.00% | -267.98% | -58.69% | -17.81% | -188.38% | -287.90% | -3.41% | -2.78% | -1.68% | 1.95% | 3.11% | 1.04% | 6.75% | 7.17% |
| Income Tax Expense | 0.00 | 0.00 | 4.16M | -831.00K | -123.80M | -636.00M | 79.09M | -8.00M | -15.28M | -32.15M | -216.58K | 8.56M | -18.45M | 8.11M | 5.62M |
| Net Income | 0.00 | 0.00 | -49.10M | -117.19M | -114.18M | -782.36M | -1.68B | -34.31M | -37.93M | -43.56M | 40.08M | 33.46M | 26.28M | 37.04M | 37.80M |
| Net Income Ratio | 0.00% | 0.00% | -267.98% | -58.69% | -17.81% | -188.38% | -302.14% | -2.77% | -1.98% | -2.27% | 1.96% | 2.48% | 3.48% | 5.54% | 6.24% |
| EPS | 0.00 | 0.00 | -1.23 | -2.93 | -2.85 | -19.56 | -41.96 | -0.86 | -0.95 | -1.09 | 1.00 | 0.84 | 0.86 | 3.77 | 3.85 |
| EPS Diluted | 0.00 | 0.00 | -1.23 | -2.93 | -2.85 | -19.56 | -41.96 | -0.86 | -0.95 | -1.09 | 1.00 | 0.84 | 0.86 | 3.73 | 3.81 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 39.92M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 39.83M | 30.56M | 9.82M | 9.82M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 39.92M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 39.83M | 30.56M | 9.92M | 9.92M |
No news found for: SYNCOM.NS
Source: https://incomestatements.info
Category: Stock Reports